Enteral nutritional support and use of diabetes-specific formulas for patients with diabetes: A systematic review and meta-analysis

Marinos Elia, Antonio Ceriello, Heiner Laube, Alan J. Sinclair, Meike Engfer, Rebecca J. Stratton

Research output: Contribution to journalArticle

Abstract

OBJECTIVE - The aim of this systematic review was to determine the benefits of nutritional support in patients with type 1 or type 2 diabetes. RESEARCH DESIGN AND METHODS - Studies utilizing an enteral nutritional support intervention (oral supplements or tube feeding) were identified using electronic databases and bibliography searches. Comparisons of interest were nutritional support versus routine care and standard versus diabetes-specific formulas (containing high proportions of monounsaturated fatty acids, fructose, and fiber). Outcomes of interest were measures of glycemia and lipid status, medication requirements, nutritional status, quality of life, complications, and mortality. Meta-analyses were performed where possible. RESULTS - A total of 23 studies (comprising 784 patients) of oral supplements (16 studies) and tube feeding (7 studies) were included in the review, and the majority compared diabetes-specific with standard formulas. Compared with standard formulas, diabetes-specific formulas significantly reduced postprandial rise in blood glucose (by 1.03 mmol/l [95% CI 0.58-1.47]; six randomized controlled trials [RCTs]), peak blood glucose concentration (by 1.59 mmol/l [86-2.32]; two RCTs), and glucose area under curve (by 7.96 mmol·l-1·min -1 [2.25-13.66]; four RCTs, i.e., by 35%) with no significant effect on HDL, total cholesterol, or triglyceride concentrations. In addition, individual studies reported a reduced requirement for insulin (26-71% lower) and fewer complications with diabetes-specific compared with standard nutritional formulas. CONCLUSIONS - This systematic review shows that short- and long-term use of diabetes-specific formulas as oral supplements and tube feeds are associated with improved glycemic control compared with standard formulas. If such nutritional support is given long term, this may have implications for reducing chronic complications of diabetes, such as cardiovascular events.

Original languageEnglish
Pages (from-to)2267-2279
Number of pages13
JournalDiabetes Care
Volume28
Issue number9
DOIs
Publication statusPublished - Sep 2005

Fingerprint

Nutritional Support
Small Intestine
Meta-Analysis
Randomized Controlled Trials
Enteral Nutrition
Diabetes Complications
Blood Glucose
Monounsaturated Fatty Acids
Bibliography
Standard of Care
Fructose
Nutritional Status
Type 2 Diabetes Mellitus
HDL Cholesterol
Area Under Curve
Triglycerides
Research Design
Quality of Life
Databases
Insulin

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Enteral nutritional support and use of diabetes-specific formulas for patients with diabetes : A systematic review and meta-analysis. / Elia, Marinos; Ceriello, Antonio; Laube, Heiner; Sinclair, Alan J.; Engfer, Meike; Stratton, Rebecca J.

In: Diabetes Care, Vol. 28, No. 9, 09.2005, p. 2267-2279.

Research output: Contribution to journalArticle

Elia, Marinos ; Ceriello, Antonio ; Laube, Heiner ; Sinclair, Alan J. ; Engfer, Meike ; Stratton, Rebecca J. / Enteral nutritional support and use of diabetes-specific formulas for patients with diabetes : A systematic review and meta-analysis. In: Diabetes Care. 2005 ; Vol. 28, No. 9. pp. 2267-2279.
@article{77e67ac0355648feab2ae1148017558d,
title = "Enteral nutritional support and use of diabetes-specific formulas for patients with diabetes: A systematic review and meta-analysis",
abstract = "OBJECTIVE - The aim of this systematic review was to determine the benefits of nutritional support in patients with type 1 or type 2 diabetes. RESEARCH DESIGN AND METHODS - Studies utilizing an enteral nutritional support intervention (oral supplements or tube feeding) were identified using electronic databases and bibliography searches. Comparisons of interest were nutritional support versus routine care and standard versus diabetes-specific formulas (containing high proportions of monounsaturated fatty acids, fructose, and fiber). Outcomes of interest were measures of glycemia and lipid status, medication requirements, nutritional status, quality of life, complications, and mortality. Meta-analyses were performed where possible. RESULTS - A total of 23 studies (comprising 784 patients) of oral supplements (16 studies) and tube feeding (7 studies) were included in the review, and the majority compared diabetes-specific with standard formulas. Compared with standard formulas, diabetes-specific formulas significantly reduced postprandial rise in blood glucose (by 1.03 mmol/l [95{\%} CI 0.58-1.47]; six randomized controlled trials [RCTs]), peak blood glucose concentration (by 1.59 mmol/l [86-2.32]; two RCTs), and glucose area under curve (by 7.96 mmol·l-1·min -1 [2.25-13.66]; four RCTs, i.e., by 35{\%}) with no significant effect on HDL, total cholesterol, or triglyceride concentrations. In addition, individual studies reported a reduced requirement for insulin (26-71{\%} lower) and fewer complications with diabetes-specific compared with standard nutritional formulas. CONCLUSIONS - This systematic review shows that short- and long-term use of diabetes-specific formulas as oral supplements and tube feeds are associated with improved glycemic control compared with standard formulas. If such nutritional support is given long term, this may have implications for reducing chronic complications of diabetes, such as cardiovascular events.",
author = "Marinos Elia and Antonio Ceriello and Heiner Laube and Sinclair, {Alan J.} and Meike Engfer and Stratton, {Rebecca J.}",
year = "2005",
month = "9",
doi = "10.2337/diacare.28.9.2267",
language = "English",
volume = "28",
pages = "2267--2279",
journal = "Diabetes Care",
issn = "1935-5548",
publisher = "American Diabetes Association Inc.",
number = "9",

}

TY - JOUR

T1 - Enteral nutritional support and use of diabetes-specific formulas for patients with diabetes

T2 - A systematic review and meta-analysis

AU - Elia, Marinos

AU - Ceriello, Antonio

AU - Laube, Heiner

AU - Sinclair, Alan J.

AU - Engfer, Meike

AU - Stratton, Rebecca J.

PY - 2005/9

Y1 - 2005/9

N2 - OBJECTIVE - The aim of this systematic review was to determine the benefits of nutritional support in patients with type 1 or type 2 diabetes. RESEARCH DESIGN AND METHODS - Studies utilizing an enteral nutritional support intervention (oral supplements or tube feeding) were identified using electronic databases and bibliography searches. Comparisons of interest were nutritional support versus routine care and standard versus diabetes-specific formulas (containing high proportions of monounsaturated fatty acids, fructose, and fiber). Outcomes of interest were measures of glycemia and lipid status, medication requirements, nutritional status, quality of life, complications, and mortality. Meta-analyses were performed where possible. RESULTS - A total of 23 studies (comprising 784 patients) of oral supplements (16 studies) and tube feeding (7 studies) were included in the review, and the majority compared diabetes-specific with standard formulas. Compared with standard formulas, diabetes-specific formulas significantly reduced postprandial rise in blood glucose (by 1.03 mmol/l [95% CI 0.58-1.47]; six randomized controlled trials [RCTs]), peak blood glucose concentration (by 1.59 mmol/l [86-2.32]; two RCTs), and glucose area under curve (by 7.96 mmol·l-1·min -1 [2.25-13.66]; four RCTs, i.e., by 35%) with no significant effect on HDL, total cholesterol, or triglyceride concentrations. In addition, individual studies reported a reduced requirement for insulin (26-71% lower) and fewer complications with diabetes-specific compared with standard nutritional formulas. CONCLUSIONS - This systematic review shows that short- and long-term use of diabetes-specific formulas as oral supplements and tube feeds are associated with improved glycemic control compared with standard formulas. If such nutritional support is given long term, this may have implications for reducing chronic complications of diabetes, such as cardiovascular events.

AB - OBJECTIVE - The aim of this systematic review was to determine the benefits of nutritional support in patients with type 1 or type 2 diabetes. RESEARCH DESIGN AND METHODS - Studies utilizing an enteral nutritional support intervention (oral supplements or tube feeding) were identified using electronic databases and bibliography searches. Comparisons of interest were nutritional support versus routine care and standard versus diabetes-specific formulas (containing high proportions of monounsaturated fatty acids, fructose, and fiber). Outcomes of interest were measures of glycemia and lipid status, medication requirements, nutritional status, quality of life, complications, and mortality. Meta-analyses were performed where possible. RESULTS - A total of 23 studies (comprising 784 patients) of oral supplements (16 studies) and tube feeding (7 studies) were included in the review, and the majority compared diabetes-specific with standard formulas. Compared with standard formulas, diabetes-specific formulas significantly reduced postprandial rise in blood glucose (by 1.03 mmol/l [95% CI 0.58-1.47]; six randomized controlled trials [RCTs]), peak blood glucose concentration (by 1.59 mmol/l [86-2.32]; two RCTs), and glucose area under curve (by 7.96 mmol·l-1·min -1 [2.25-13.66]; four RCTs, i.e., by 35%) with no significant effect on HDL, total cholesterol, or triglyceride concentrations. In addition, individual studies reported a reduced requirement for insulin (26-71% lower) and fewer complications with diabetes-specific compared with standard nutritional formulas. CONCLUSIONS - This systematic review shows that short- and long-term use of diabetes-specific formulas as oral supplements and tube feeds are associated with improved glycemic control compared with standard formulas. If such nutritional support is given long term, this may have implications for reducing chronic complications of diabetes, such as cardiovascular events.

UR - http://www.scopus.com/inward/record.url?scp=24144438663&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24144438663&partnerID=8YFLogxK

U2 - 10.2337/diacare.28.9.2267

DO - 10.2337/diacare.28.9.2267

M3 - Article

C2 - 16123506

AN - SCOPUS:24144438663

VL - 28

SP - 2267

EP - 2279

JO - Diabetes Care

JF - Diabetes Care

SN - 1935-5548

IS - 9

ER -